메뉴 건너뛰기




Volumn 16, Issue 5, 2017, Pages 547-559

Tyrosine kinase inhibitors: potential use and safety considerations in HIV-1 infection

Author keywords

chronic myeloid leukemia; HIV AIDS; immunomodulation; T cell activation; Tyrosine kinase inhibitors; viral reservoirs

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; IMMUNOMODULATING AGENT; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PROTEIN KINASE INHIBITOR;

EID: 85018741252     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1080/14740338.2017.1313224     Document Type: Review
Times cited : (13)

References (115)
  • 1
    • 0032742547 scopus 로고    scopus 로고
    • Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells
    • PubMed PMID: 10558989
    • Zhang Z, Schuler T, Zupancic M, et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science. 1999;286(5443):1353–1357. PubMed PMID:10558989.
    • (1999) Science , vol.286 , Issue.5443 , pp. 1353-1357
    • Zhang, Z.1    Schuler, T.2    Zupancic, M.3
  • 2
    • 0025342694 scopus 로고
    • HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure
    • PubMed PMID: 2331748
    • Zack JA, Arrigo SJ, Weitsman SR, et al., HIV-1 entry into quiescent primary lymphocytes:molecular analysis reveals a labile, latent viral structure. Cell. 1990;612:213–222.PubMed PMID:2331748.
    • (1990) Cell , vol.61 , Issue.2 , pp. 213-222
    • Zack, J.A.1    Arrigo, S.J.2    Weitsman, S.R.3
  • 3
    • 15644373354 scopus 로고    scopus 로고
    • Activation of blood T lymphocytes down-regulates CXCR4 expression and interferes with propagation of X4 HIV strains
    • 28:10<3192:: AID-IMMU3192>3.0.CO;2-E. PubMed PMID: 9808188
    • Bermejo M, Martin-Serrano J, Oberlin E, et al. Activation of blood T lymphocytes down-regulates CXCR4 expression and interferes with propagation of X4 HIV strains. Eur J Immunol. 1998; 28(10):3192–3204. 28:10<3192::AID-IMMU3192>3.0.CO;2-E. PubMed PMID:9808188. DOI:10.1002/(SICI)1521-4141(199810)
    • (1998) Eur J Immunol , vol.28 , Issue.10 , pp. 3192-3204
    • Bermejo, M.1    Martin-Serrano, J.2    Oberlin, E.3
  • 4
    • 84869170593 scopus 로고    scopus 로고
    • SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells
    • 2964. PubMed PMID: 22972397; PubMed Central PMCID: PMCPMC3828732
    • Baldauf HM, Pan X, Erikson E, et al. SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat Med. 2012;18(11):1682–1687. 2964. PubMed PMID:22972397; PubMed Central PMCID:PMCPMC3828732. DOI:10.1038/nm•• This article highlights for the first time one of the major mechanisms of resistance to infection in resting CD4 lymphocytes, the presence of the restriction factor SAMHD11.
    • (2012) Nat Med , vol.18 , Issue.11 , pp. 1682-1687
    • Baldauf, H.M.1    Pan, X.2    Erikson, E.3
  • 5
    • 0026770379 scopus 로고
    • Active nuclear import of human immunodeficiency virus type 1 preintegration complexes
    • PubMed PMID: 1631159; PubMed Central PMCID: PMCPMC49545
    • Bukrinsky MI, Sharova N, Dempsey MP, et al. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci U S A. 1992;89(14):6580–6584. PubMed PMID:1631159; PubMed Central PMCID:PMCPMC49545.
    • (1992) Proc Natl Acad Sci U S A , vol.89 , Issue.14 , pp. 6580-6584
    • Bukrinsky, M.I.1    Sharova, N.2    Dempsey, M.P.3
  • 6
    • 0028987950 scopus 로고
    • Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes
    • Alcami J, Lain De LT, Folgueira L, et al. Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. Embo J. 1995;14(7):1552–1560.
    • (1995) Embo J , vol.14 , Issue.7 , pp. 1552-1560
    • Alcami, J.1    Lain De, L.T.2    Folgueira, L.3
  • 7
    • 59449101108 scopus 로고    scopus 로고
    • Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells
    • Bosque A, Planelles V., Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. Blood. 2009;113(1):58–65. DOI:10.1182/blood-2008-07-168393
    • (2009) Blood , vol.113 , Issue.1 , pp. 58-65
    • Bosque, A.1    Planelles, V.2
  • 8
    • 70350148394 scopus 로고    scopus 로고
    • Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs
    • PubMed PMID: 19834480
    • Coiras M, Lopez-Huertas MR, Perez-Olmeda M, et al. Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. Nat Rev Microbiol. 2009;7(11):798–812. PubMed PMID:19834480. DOI:10.1038/nrmicro2223•• A classical review covering both the molecular mechanisms of HIV latency and reactivation and the different strategies to tackle the viral reservoirs.
    • (2009) Nat Rev Microbiol , vol.7 , Issue.11 , pp. 798-812
    • Coiras, M.1    Lopez-Huertas, M.R.2    Perez-Olmeda, M.3
  • 9
    • 14444273439 scopus 로고    scopus 로고
    • Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
    • PubMed PMID: 9360927
    • Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.Science.1997;278(5341):1295–1300.PubMed PMID:9360927.• A classical paper first describing and quantifying the viral reservoir in CD4 lymphocytes from HIV-infected patients.
    • (1997) Science , vol.278 , Issue.5341 , pp. 1295-1300
    • Finzi, D.1    Hermankova, M.2    Pierson, T.3
  • 10
    • 4644342929 scopus 로고    scopus 로고
    • CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract
    • PubMed PMID: 15365096; PubMed Central PMCID: PMCPMC2211962
    • Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004; 200(6):749–759. PubMed PMID:15365096; PubMed Central PMCID:PMCPMC2211962. DOI:10.1084/jem.20040874
    • (2004) J Exp Med , vol.200 , Issue.6 , pp. 749-759
    • Brenchley, J.M.1    Schacker, T.W.2    Ruff, L.E.3
  • 11
    • 79251480064 scopus 로고    scopus 로고
    • Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue
    • PubMed PMID: 21111238; PubMed Central PMCID: PMCPMC3026834
    • Doitsh G, Cavrois M, Lassen KG, et al. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell. 2010; 143(5):789–801. PubMed PMID:21111238; PubMed Central PMCID:PMCPMC3026834. DOI:10.1016/j.cell.2010.11.001
    • (2010) Cell , vol.143 , Issue.5 , pp. 789-801
    • Doitsh, G.1    Cavrois, M.2    Lassen, K.G.3
  • 12
    • 84892739389 scopus 로고    scopus 로고
    • Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection
    • PubMed PMID: 24356306; PubMed Central PMCID: PMCPMC4047036
    • Doitsh G, Galloway NL, Geng X, et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature. 2014; 505(7484):509–514. PubMed PMID:24356306; PubMed Central PMCID:PMCPMC4047036. DOI:10.1038/nature12940
    • (2014) Nature , vol.505 , Issue.7484 , pp. 509-514
    • Doitsh, G.1    Galloway, N.L.2    Geng, X.3
  • 13
    • 4644289983 scopus 로고    scopus 로고
    • Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract
    • PubMed PMID: 15365095; PubMed Central PMCID: PMCPMC2211967
    • Mehandru S, Poles MA, Tenner-Racz K, et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med. 2004; 200(6):761–770. PubMed PMID:15365095; PubMed Central PMCID:PMCPMC2211967. DOI:10.1084/jem.20041196
    • (2004) J Exp Med , vol.200 , Issue.6 , pp. 761-770
    • Mehandru, S.1    Poles, M.A.2    Tenner-Racz, K.3
  • 14
    • 84892946076 scopus 로고    scopus 로고
    • IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV
    • PubMed PMID: 24356113; PubMed Central PMCID: PMCPMC3976200
    • Monroe KM, Yang Z, Johnson JR, et al. IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science. 2014;343(6169):428–432. PubMed PMID:24356113; PubMed Central PMCID:PMCPMC3976200. DOI:10.1126/science.1243640•• In this article, a new mechanisms of cell death linked to the increase of reverse transcripts in the cytosol of infected lymphocytes due to HIV-1 restriction by SAMHD1 is proposed.
    • (2014) Science , vol.343 , Issue.6169 , pp. 428-432
    • Monroe, K.M.1    Yang, Z.2    Johnson, J.R.3
  • 15
    • 84963878365 scopus 로고    scopus 로고
    • Prime, Shock, and Kill: priming CD4 T Cells from HIV Patients with a BCL-2 antagonist before HIV reactivation reduces HIV reservoir size
    • PubMed PMID: 26842479; PubMed Central PMCID: PMCPMC4810548
    • Cummins NW, Sainski AM, Dai H, et al. Prime, Shock, and Kill:priming CD4 T Cells from HIV Patients with a BCL-2 antagonist before HIV reactivation reduces HIV reservoir size. J Virol. 2016; 90(8):4032–4048. PubMed PMID:26842479; PubMed Central PMCID:PMCPMC4810548. DOI:10.1128/JVI.03179-15
    • (2016) J Virol , vol.90 , Issue.8 , pp. 4032-4048
    • Cummins, N.W.1    Sainski, A.M.2    Dai, H.3
  • 16
    • 84875123749 scopus 로고    scopus 로고
    • The presence of HIV-1 Tat protein second exon delays fas protein-mediated apoptosis in CD4+ T lymphocytes: a potential mechanism for persistent viral production
    • PubMed PMID: 23364796; PubMed Central PMCID: PMCPMC3597804
    • Lopez-Huertas MR, Mateos E, Sanchez Del Cojo M, et al. The presence of HIV-1 Tat protein second exon delays fas protein-mediated apoptosis in CD4+ T lymphocytes:a potential mechanism for persistent viral production. J Biol Chem. 2013; 288(11):7626–7644. PubMed PMID:23364796; PubMed Central PMCID:PMCPMC3597804. DOI:10.1074/jbc.M112.408294
    • (2013) J Biol Chem , vol.288 , Issue.11 , pp. 7626-7644
    • Lopez-Huertas, M.R.1    Mateos, E.2    Sanchez Del Cojo, M.3
  • 17
    • 12644251972 scopus 로고    scopus 로고
    • The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia
    • PubMed PMID: 8990195; PubMed Central PMCID: PMCPMC19306
    • Pantaleo G, Demarest JF, Schacker T, et al. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci U S A. 1997;94(1):254–258. PubMed PMID:8990195; PubMed Central PMCID:PMCPMC19306.
    • (1997) Proc Natl Acad Sci U S A , vol.94 , Issue.1 , pp. 254-258
    • Pantaleo, G.1    Demarest, J.F.2    Schacker, T.3
  • 18
    • 0030665257 scopus 로고    scopus 로고
    • Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
    • PubMed PMID: 9367954
    • Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science. 1997;278(5342):1447–1450. PubMed PMID:9367954.
    • (1997) Science , vol.278 , Issue.5342 , pp. 1447-1450
    • Rosenberg, E.S.1    Billingsley, J.M.2    Caliendo, A.M.3
  • 19
    • 0032505665 scopus 로고    scopus 로고
    • Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease. Immunology study group of Spanish EARTH-1 Study
    • PubMed PMID: 9777842
    • Plana M, Garcia F, Gallart T, et al., Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease. Immunology study group of Spanish EARTH-1 Study. Lancet. 1998;3529135:1194–1195.PubMed PMID:9777842.
    • (1998) Lancet , vol.352 , Issue.9135 , pp. 1194-1195
    • Plana, M.1    Garcia, F.2    Gallart, T.3
  • 20
    • 84981318384 scopus 로고    scopus 로고
    • Multiple origins of virus persistence during natural control of HIV infection
    • PubMed PMID: 27453467; PubMed Central PMCID: PMCPMC4983216
    • Boritz EA, Darko S, Swaszek L, et al. Multiple origins of virus persistence during natural control of HIV infection. Cell. 2016;166(4):1004–1015. PubMed PMID:27453467; PubMed Central PMCID:PMCPMC4983216. DOI:10.1016/j.cell.2016.06.039• A new actively replicating HIV-1 reservoir–CD4 T-helper follicular cells–that are placed in a CTL-resistant sanctuary is described.
    • (2016) Cell , vol.166 , Issue.4 , pp. 1004-1015
    • Boritz, E.A.1    Darko, S.2    Swaszek, L.3
  • 21
    • 0037007670 scopus 로고    scopus 로고
    • HIV preferentially infects HIV-specific CD4+ T cells
    • PubMed PMID: 11986671
    • Douek DC, Brenchley JM, Betts MR, et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature. 2002;417(6884):95–98. PubMed PMID:11986671. DOI:10.1038/417095a• In this article, the paradoxical destruction of CD4-specific lymphocytes targeting the HIV-1 virus due to enhanced susceptibility to infection is described as a qualitative mechanism of immune suppression.
    • (2002) Nature , vol.417 , Issue.6884 , pp. 95-98
    • Douek, D.C.1    Brenchley, J.M.2    Betts, M.R.3
  • 22
    • 22344452391 scopus 로고    scopus 로고
    • Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells
    • Lore K, Smed-Sorensen A, Vasudevan J, et al. Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells. J Exp Med. 2005;201(12):2023–2033. DOI:10.1084/jem.20042413
    • (2005) J Exp Med , vol.201 , Issue.12 , pp. 2023-2033
    • Lore, K.1    Smed-Sorensen, A.2    Vasudevan, J.3
  • 23
    • 84957558724 scopus 로고    scopus 로고
    • Persistent HIV-1 replication maintains the tissue reservoir during therapy
    • PubMed PMID: 26814962; PubMed Central PMCID: PMCPMC4865637
    • Lorenzo-Redondo R, Fryer HR, Bedford T, et al. Persistent HIV-1 replication maintains the tissue reservoir during therapy. Nature. 2016; 530(7588):51–56. PubMed PMID:26814962; PubMed Central PMCID:PMCPMC4865637. DOI:10.1038/nature16933
    • (2016) Nature , vol.530 , Issue.7588 , pp. 51-56
    • Lorenzo-Redondo, R.1    Fryer, H.R.2    Bedford, T.3
  • 24
    • 0036192919 scopus 로고    scopus 로고
    • Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy
    • PubMed PMID: 11877476; PubMed Central PMCID: PMCPMC150896
    • Rizzardi GP, Harari A, Capiluppi B, et al. Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy. J Clin Invest. 2002;109(5):681–688. PubMed PMID:11877476; PubMed Central PMCID:PMCPMC150896. DOI:10.1172/JCI14522• First paper describing the role of immune suppression to preserve CD4 lymphocyte counts in acutely infected HIV patients. Unfortunately, this article was not confirmed by other authors.
    • (2002) J Clin Invest , vol.109 , Issue.5 , pp. 681-688
    • Rizzardi, G.P.1    Harari, A.2    Capiluppi, B.3
  • 25
    • 0036534889 scopus 로고    scopus 로고
    • Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantation
    • PubMed PMID: 11917239
    • Calabrese LH, Lederman MM, Spritzler J, et al. Placebo-controlled trial of cyclosporin-A in HIV-1 disease:implications for solid organ transplantation. J Acquir Immune Defic Syndr. 2002;29(4):356–362. PubMed PMID:11917239.
    • (2002) J Acquir Immune Defic Syndr , vol.29 , Issue.4 , pp. 356-362
    • Calabrese, L.H.1    Lederman, M.M.2    Spritzler, J.3
  • 26
    • 77950936860 scopus 로고    scopus 로고
    • The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection
    • PubMed PMID: 20235838; PubMed Central PMCID: PMCPMC2851487
    • Markowitz M, Vaida F, Hare CB, et al. The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection. J Infect Dis. 2010; 201(9):1298–1302. PubMed PMID:20235838; PubMed Central PMCID:PMCPMC2851487. DOI:10.1086/651664
    • (2010) J Infect Dis , vol.201 , Issue.9 , pp. 1298-1302
    • Markowitz, M.1    Vaida, F.2    Hare, C.B.3
  • 27
    • 0023901012 scopus 로고
    • Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease
    • PubMed PMID: 3258211
    • Andrieu JM, Even P, Venet A, et al. Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease. Clin Immunol Immunopathol. 1988;47(2):181–198. PubMed PMID:3258211.
    • (1988) Clin Immunol Immunopathol , vol.47 , Issue.2 , pp. 181-198
    • Andrieu, J.M.1    Even, P.2    Venet, A.3
  • 28
    • 0034457544 scopus 로고    scopus 로고
    • Cyclosporin A in combination with HAART in primary HIV-1 infection
    • PubMed PMID: 10763900
    • Rizzardi GP, Vaccarezza M, Capiluppi B, et al., Cyclosporin A in combination with HAART in primary HIV-1 infection. J Biol Regul Homeost Agents. 2000;141:79–81.PubMed PMID:10763900.
    • (2000) J Biol Regul Homeost Agents , vol.14 , Issue.1 , pp. 79-81
    • Rizzardi, G.P.1    Vaccarezza, M.2    Capiluppi, B.3
  • 29
    • 85031000845 scopus 로고    scopus 로고
    • Cyclosporine A in addition to standard ART during primary HIV-1 infection: pilot randomized clinical trial
    • PubMed PMID: 27999018
    • Nicolas D, Ambrosioni J, Sued O, et al. Cyclosporine A in addition to standard ART during primary HIV-1 infection:pilot randomized clinical trial. J Antimicrob Chemother. 2016;dkw462. PubMed PMID:27999018. DOI:10.1093/jac/dkw462
    • (2016) J Antimicrob Chemother
    • Nicolas, D.1    Ambrosioni, J.2    Sued, O.3
  • 30
    • 0024381749 scopus 로고
    • Cyclosporine-induced deterioration in patients with AIDS
    • PubMed PMID: 2720530; PubMed Central PMCID: PMCPMC1269983
    • Phillips A, Wainberg MA, Coates R, et al. Cyclosporine-induced deterioration in patients with AIDS. Cmaj. 1989;140(12):1456–1460. PubMed PMID:2720530; PubMed Central PMCID:PMCPMC1269983.
    • (1989) Cmaj , vol.140 , Issue.12 , pp. 1456-1460
    • Phillips, A.1    Wainberg, M.A.2    Coates, R.3
  • 31
    • 0033942250 scopus 로고    scopus 로고
    • Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo
    • Epub 768. PubMed Central PMCID: PMC10888924
    • Chapuis AG, Paolo Rizzardi G, D’Agostino C, et al. Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo. Nat Med. 2000;6:7. Epub 768. PubMed Central PMCID:PMC10888924.
    • (2000) Nat Med , vol.6 , pp. 7
    • Chapuis, A.G.1    Paolo Rizzardi, G.2    D’Agostino, C.3
  • 32
    • 0035870543 scopus 로고    scopus 로고
    • A pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection
    • PubMed PMID: 11391161
    • Coull JJ, Turner D, Melby T, et al., A pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection. J Acquir Immune Defic Syndr. 2001;265:423–434.PubMed PMID:11391161.
    • (2001) J Acquir Immune Defic Syndr , vol.26 , Issue.5 , pp. 423-434
    • Coull, J.J.1    Turner, D.2    Melby, T.3
  • 33
    • 3843110460 scopus 로고    scopus 로고
    • Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients
    • PubMed PMID: 15353978
    • Sankatsing SU, Jurriaans S, Van Swieten P, et al. Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients. Aids. 2004;18(14):1925–1931. PubMed PMID:15353978.
    • (2004) Aids , vol.18 , Issue.14 , pp. 1925-1931
    • Sankatsing, S.U.1    Jurriaans, S.2    Van Swieten, P.3
  • 34
    • 3042857765 scopus 로고    scopus 로고
    • Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot study
    • PubMed PMID: 15213566
    • Garcia F, Plana M, Arnedo M, et al. Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection:a randomized pilot study. J Acquir Immune Defic Syndr. 2004;36(3):823–830. PubMed PMID:15213566.
    • (2004) J Acquir Immune Defic Syndr , vol.36 , Issue.3 , pp. 823-830
    • Garcia, F.1    Plana, M.2    Arnedo, M.3
  • 35
    • 1642350307 scopus 로고    scopus 로고
    • Immunosuppressive drugs as an adjuvant to HIV treatment
    • PubMed PMID: 14963070
    • Fumero E, Garcia F, Gatell JM., Immunosuppressive drugs as an adjuvant to HIV treatment. J Antimicrob Chemother. 2004;53(3):415–417. PubMed PMID:14963070. DOI:10.1093/jac/dkh123• A review on the potential benefit of immunomodulatory drugs in HIV infection.
    • (2004) J Antimicrob Chemother , vol.53 , Issue.3 , pp. 415-417
    • Fumero, E.1    Garcia, F.2    Gatell, J.M.3
  • 36
    • 0037414987 scopus 로고    scopus 로고
    • A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions: a randomized study
    • PubMed PMID: 12478068
    • Garcia F, Plana M, Arnedo M, et al. A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions:a randomized study. Aids. 2003; 17(1):43–51. PubMed PMID:12478068. DOI:10.1097/01.aids.0000042953.95433.79
    • (2003) Aids , vol.17 , Issue.1 , pp. 43-51
    • Garcia, F.1    Plana, M.2    Arnedo, M.3
  • 37
    • 80054895503 scopus 로고    scopus 로고
    • A motif in the V3 domain of the kinase PKC-theta determines its localization in the immunological synapse and functions in T cells via association with CD28
    • Kong KF, Yokosuka T, Canonigo-Balancio AJ, et al. A motif in the V3 domain of the kinase PKC-theta determines its localization in the immunological synapse and functions in T cells via association with CD28. Nat Immunol. 2011;12(11):1105–1112. DOI:10.1038/ni
    • (2011) Nat Immunol , vol.12 , Issue.11 , pp. 1105-1112
    • Kong, K.F.1    Yokosuka, T.2    Canonigo-Balancio, A.J.3
  • 38
    • 77955013336 scopus 로고    scopus 로고
    • PKCtheta is necessary for efficient activation of NFkappaB, NFAT, and AP-1 during positive selection of thymocytes
    • Gruber T, Pfeifhofer-Obermair C, Baier G. PKCtheta is necessary for efficient activation of NFkappaB, NFAT, and AP-1 during positive selection of thymocytes. Immunol Lett. 2010;132(1–2):6–11. DOI:10.1016/j.imlet.2010.04.008
    • (2010) Immunol Lett , vol.132 , Issue.1-2 , pp. 6-11
    • Gruber, T.1    Pfeifhofer-Obermair, C.2    Baier, G.3
  • 39
    • 84874219989 scopus 로고    scopus 로고
    • Regulation of PKC-theta function by phosphorylation in T cell receptor signaling
    • PubMed PMID: 22798961; PubMed Central PMCID: PMCPMC3393885
    • Wang X, Chuang HC, Li JP, et al. Regulation of PKC-theta function by phosphorylation in T cell receptor signaling. Front Immunol. 2012;3:197. PubMed PMID:22798961; PubMed Central PMCID:PMCPMC3393885. DOI:10.3389/fimmu.2012.00197
    • (2012) Front Immunol , vol.3 , pp. 197
    • Wang, X.1    Chuang, H.C.2    Li, J.P.3
  • 40
    • 0031439247 scopus 로고    scopus 로고
    • Cellular functions regulated by Src family kinases
    • PubMed PMID: 9442882
    • Thomas SM, Brugge JS, Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol. 1997;13:513–609. PubMed PMID:9442882. DOI:10.1146/annurev.cellbio.13.1.513
    • (1997) Annu Rev Cell Dev Biol , vol.13 , pp. 513-609
    • Thomas, S.M.1    Brugge, J.S.2
  • 41
    • 0024751217 scopus 로고
    • Expression of a novel form of the fyn proto-oncogene in hematopoietic cells
    • PubMed PMID: 2488273
    • Cooke MP, Perlmutter RM, Expression of a novel form of the fyn proto-oncogene in hematopoietic cells. New Biol. 1989;11:66–74.PubMed PMID:2488273.
    • (1989) New Biol , vol.1 , Issue.1 , pp. 66-74
    • Cooke, M.P.1    Perlmutter, R.M.2
  • 42
    • 0028973001 scopus 로고
    • Comparison of p56lck and p59fyn protein expression in thymocyte subsets, peripheral T cells, NK cells, and lymphoid cell lines
    • PubMed PMID: 7594580
    • Olszowy MW, Leuchtmann PL, Veillette A, et al., Comparison of p56lck and p59fyn protein expression in thymocyte subsets, peripheral T cells, NK cells, and lymphoid cell lines. J Immunol. 1995;1559:4236–4240.PubMed PMID:7594580.
    • (1995) J Immunol , vol.155 , Issue.9 , pp. 4236-4240
    • Olszowy, M.W.1    Leuchtmann, P.L.2    Veillette, A.3
  • 43
    • 7944231534 scopus 로고    scopus 로고
    • Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation
    • PubMed PMID: 15489916
    • Palacios EH, Weiss A. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene. 2004;23(48):7990–8000. PubMed PMID:15489916. DOI:10.1038/sj.onc.1208074• An interesting revision on the role of tyrosine kinases in lymphocyte activation.
    • (2004) Oncogene , vol.23 , Issue.48 , pp. 7990-8000
    • Palacios, E.H.1    Weiss, A.2
  • 44
    • 0025237554 scopus 로고
    • Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs
    • PubMed PMID: 2107025
    • Turner JM, Brodsky MH, Irving BA, et al., Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell. 1990;605:755–765.PubMed PMID:2107025.
    • (1990) Cell , vol.60 , Issue.5 , pp. 755-765
    • Turner, J.M.1    Brodsky, M.H.2    Irving, B.A.3
  • 45
    • 0028279060 scopus 로고
    • Distinct intracellular localization of Lck and Fyn protein tyrosine kinases in human T lymphocytes
    • PubMed PMID: 7513706; PubMed Central PMCID: PMCPMC2119993
    • Ley SC, Marsh M, Bebbington CR, et al., Distinct intracellular localization of Lck and Fyn protein tyrosine kinases in human T lymphocytes. J Cell Biol. 1994;1253:639–649.PubMed PMID:7513706; PubMed Central PMCID:PMCPMC2119993.
    • (1994) J Cell Biol , vol.125 , Issue.3 , pp. 639-649
    • Ley, S.C.1    Marsh, M.2    Bebbington, C.R.3
  • 46
    • 0034695891 scopus 로고    scopus 로고
    • Lck domains differentially contribute to pre-T cell receptor (TCR)- and TCR-alpha/beta-regulated developmental transitions
    • PubMed PMID: 10684862; PubMed Central PMCID: PMCPMC2195836
    • Lin K, Longo NS, Wang X, et al., Lck domains differentially contribute to pre-T cell receptor (TCR)- and TCR-alpha/beta-regulated developmental transitions. J Exp Med. 2000;1914:703–716.PubMed PMID:10684862; PubMed Central PMCID:PMCPMC2195836.
    • (2000) J Exp Med , vol.191 , Issue.4 , pp. 703-716
    • Lin, K.1    Longo, N.S.2    Wang, X.3
  • 47
    • 84960362759 scopus 로고    scopus 로고
    • IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, improving early steps of HIV-1 life cycle
    • PubMed PMID: 26923586; PubMed Central PMCID: PMCPMC5063304
    • Coiras M, Bermejo M, Descours B, et al. IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, improving early steps of HIV-1 life cycle. Cell Rep. 2016;14(9):2100–2107. PubMed PMID:26923586; PubMed Central PMCID:PMCPMC5063304. DOI:10.1016/j.celrep.2016.02.022•• First description of the ability of dasatinib to interfere with SAMHD1.
    • (2016) Cell Rep , vol.14 , Issue.9 , pp. 2100-2107
    • Coiras, M.1    Bermejo, M.2    Descours, B.3
  • 48
    • 9644266657 scopus 로고    scopus 로고
    • Right time, right place: the organization of membrane proximal signaling
    • Simeoni L, Smida M, Posevitz V, et al. Right time, right place:the organization of membrane proximal signaling. Semin Immunol. 2005;17(1):35–49. DOI:10.1016/j.smim.2004.09.002
    • (2005) Semin Immunol , vol.17 , Issue.1 , pp. 35-49
    • Simeoni, L.1    Smida, M.2    Posevitz, V.3
  • 49
    • 0031897632 scopus 로고    scopus 로고
    • NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses
    • PubMed PMID: 9597130
    • Ghosh S, May MJ, Kopp EB, NF-kappa B and Rel proteins:evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 1998;16:225–260. PubMed PMID:9597130. DOI:10.1146/annurev.immunol.16.1.225
    • (1998) Annu Rev Immunol , vol.16 , pp. 225-260
    • Ghosh, S.1    May, M.J.2    Kopp, E.B.3
  • 50
    • 0035139943 scopus 로고    scopus 로고
    • Hostile takeovers: viral appropriation of the NF-kappaB pathway
    • Hiscott J, Kwon H, Genin P. Hostile takeovers:viral appropriation of the NF-kappaB pathway. J Clin Invest. 2001;107(2):143–151. DOI:10.1172/JCI11918
    • (2001) J Clin Invest , vol.107 , Issue.2 , pp. 143-151
    • Hiscott, J.1    Kwon, H.2    Genin, P.3
  • 51
    • 0032571002 scopus 로고    scopus 로고
    • Inducible expression of IkappaBalpha repressor mutants interferes with NF-kappaB activity and HIV-1 replication in Jurkat T cells
    • PubMed PMID: 9516441
    • Kwon H, Pelletier N, DeLuca C, et al. Inducible expression of IkappaBalpha repressor mutants interferes with NF-kappaB activity and HIV-1 replication in Jurkat T cells. J Biol Chem. 1998;273(13):7431–7440. PubMed PMID:9516441.
    • (1998) J Biol Chem , vol.273 , Issue.13 , pp. 7431-7440
    • Kwon, H.1    Pelletier, N.2    DeLuca, C.3
  • 52
    • 0033581013 scopus 로고    scopus 로고
    • Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappaB (IkappaB-alphaS32/36A) and the implications for vaccine development
    • PubMed PMID: 10364191
    • Quinto I, Mallardo M, Baldassarre F, et al., Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappaB (IkappaB-alphaS32/36A) and the implications for vaccine development. J Biol Chem. 1999;27425:17567–17572.PubMed PMID:10364191.
    • (1999) J Biol Chem , vol.274 , Issue.25 , pp. 17567-17572
    • Quinto, I.1    Mallardo, M.2    Baldassarre, F.3
  • 53
    • 84929942528 scopus 로고    scopus 로고
    • Analysis of protein kinase C theta inhibitors for the control of HIV-1 replication in human CD4+ T cells reveals an effect on retrotranscription in addition to viral transcription
    • PubMed PMID: 25732195
    • Bermejo M, Lopez-Huertas MR, Hedgpeth J, et al. Analysis of protein kinase C theta inhibitors for the control of HIV-1 replication in human CD4+ T cells reveals an effect on retrotranscription in addition to viral transcription. Biochem Pharmacol. 2015; 94(4):241–256. PubMed PMID:25732195. DOI:10.1016/j.bcp.2015.02.009
    • (2015) Biochem Pharmacol , vol.94 , Issue.4 , pp. 241-256
    • Bermejo, M.1    Lopez-Huertas, M.R.2    Hedgpeth, J.3
  • 54
    • 84957899906 scopus 로고    scopus 로고
    • Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells
    • PubMed PMID: 26851491
    • Bermejo M, Lopez-Huertas MR, Garcia-Perez J, et al. Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells. Biochem Pharmacol. 2016;106:30–45. PubMed PMID:26851491. DOI:10.1016/j.bcp.2016.02.002• First description of the role of tyrosine kinase inhibitors in SAMHD1 regulation.
    • (2016) Biochem Pharmacol , vol.106 , pp. 30-45
    • Bermejo, M.1    Lopez-Huertas, M.R.2    Garcia-Perez, J.3
  • 55
    • 33644651466 scopus 로고    scopus 로고
    • Chronic myelogenous leukemia
    • D’Antonio J. Chronic myelogenous leukemia. Clin J Oncol Nurs. 2005;9(5):535–538. DOI:10.1188/05.CJON.535-538
    • (2005) Clin J Oncol Nurs , vol.9 , Issue.5 , pp. 535-538
    • D’Antonio, J.1
  • 56
    • 84873583054 scopus 로고    scopus 로고
    • Prognostically significant fusion oncogenes in Pakistani patients with adult acute lymphoblastic leukemia and their association with disease biology and outcome
    • PubMed PMID: 22994759
    • Sabir N, Iqbal Z, Aleem A, et al. Prognostically significant fusion oncogenes in Pakistani patients with adult acute lymphoblastic leukemia and their association with disease biology and outcome. Asian Pac J Cancer Prev. 2012;13(7):3349–3355. PubMed PMID:22994759.
    • (2012) Asian Pac J Cancer Prev , vol.13 , Issue.7 , pp. 3349-3355
    • Sabir, N.1    Iqbal, Z.2    Aleem, A.3
  • 57
    • 84989287617 scopus 로고    scopus 로고
    • Chronic myeloid leukemia in patient with the Klinefelter syndrome
    • PubMed PMID: 27685529
    • Andreieva SV, Korets KV, Kyselova OA, et al., Chronic myeloid leukemia in patient with the Klinefelter syndrome. Exp Oncol. 2016;383:195–197.PubMed PMID:27685529.
    • (2016) Exp Oncol , vol.38 , Issue.3 , pp. 195-197
    • Andreieva, S.V.1    Korets, K.V.2    Kyselova, O.A.3
  • 58
    • 0033614446 scopus 로고    scopus 로고
    • Chronic myeloid leukemia
    • Sawyers CL. Chronic myeloid leukemia. N Engl J Med. 1999;340(17):1330–1340. DOI:10.1056/NEJM199904293401706
    • (1999) N Engl J Med , vol.340 , Issue.17 , pp. 1330-1340
    • Sawyers, C.L.1
  • 59
    • 70450193142 scopus 로고    scopus 로고
    • Imatinib and beyond–exploring the full potential of targeted therapy for CML
    • Quintas-Cardama A, Kantarjian H, Cortes J. Imatinib and beyond–exploring the full potential of targeted therapy for CML. Nat Rev Clin Oncol. 2009;6(9):535–543. DOI:10.1038/nrclinonc.2009.112
    • (2009) Nat Rev Clin Oncol , vol.6 , Issue.9 , pp. 535-543
    • Quintas-Cardama, A.1    Kantarjian, H.2    Cortes, J.3
  • 60
    • 83755178897 scopus 로고    scopus 로고
    • Development of an effective therapy for chronic myelogenous leukemia
    • Woessner DW, Lim CS, Deininger MW. Development of an effective therapy for chronic myelogenous leukemia. Cancer J. 2011;17(6):477–486. DOI:10.1097/PPO.0b013e318237e5b7
    • (2011) Cancer J , vol.17 , Issue.6 , pp. 477-486
    • Woessner, D.W.1    Lim, C.S.2    Deininger, M.W.3
  • 61
    • 84868354463 scopus 로고    scopus 로고
    • Off-target effects of BCR-ABL1 inhibitors and their potential long-term implications in patients with chronic myeloid leukemia
    • Steegmann JL, Cervantes F, Le Coutre P, et al. Off-target effects of BCR-ABL1 inhibitors and their potential long-term implications in patients with chronic myeloid leukemia. Leuk Lymphoma. 2012;53(12):2351–2361. DOI:10.3109/10428194.2012.695779
    • (2012) Leuk Lymphoma , vol.53 , Issue.12 , pp. 2351-2361
    • Steegmann, J.L.1    Cervantes, F.2    Le Coutre, P.3
  • 62
    • 84955415070 scopus 로고    scopus 로고
    • Diagnosis and treatment of chronic myeloid leukemia in 2015
    • PubMed PMID: 26434969
    • Thompson PA, Kantarjian HM, Cortes JE. Diagnosis and treatment of chronic myeloid leukemia in 2015. Mayo Clin Proc. 2015;90(10):1440–1454. PubMed PMID:26434969. DOI:10.1016/j.mayocp.2015.08.010• An interesting revision on the treatment of chronic myeloid leukemia, describing the different tyrosine kinase inhibitors.
    • (2015) Mayo Clin Proc , vol.90 , Issue.10 , pp. 1440-1454
    • Thompson, P.A.1    Kantarjian, H.M.2    Cortes, J.E.3
  • 63
    • 84973137731 scopus 로고    scopus 로고
    • European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
    • PubMed PMID: 27121688; PubMed Central PMCID: PMCPMC4991363
    • Steegmann JL, Baccarani M, Breccia M, et al. European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia. Leukemia. 2016; 30(8):1648–1671. PubMed PMID:27121688; PubMed Central PMCID:PMCPMC4991363. DOI:10.1038/leu.2016.104
    • (2016) Leukemia , vol.30 , Issue.8 , pp. 1648-1671
    • Steegmann, J.L.1    Baccarani, M.2    Breccia, M.3
  • 64
    • 21144451094 scopus 로고    scopus 로고
    • In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants
    • PubMed PMID: 15930265
    • O’Hare T, Walters DK, Stoffregen EP, et al. In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants. Cancer Res. 2005; 65(11):4500–4505. PubMed PMID:15930265. DOI:10.1158/0008-5472.CAN-05-0259
    • (2005) Cancer Res , vol.65 , Issue.11 , pp. 4500-4505
    • O’Hare, T.1    Walters, D.K.2    Stoffregen, E.P.3
  • 65
    • 33845806858 scopus 로고    scopus 로고
    • In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells
    • PubMed PMID: 17114238
    • Puttini M, Coluccia AM, Boschelli F, et al. In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells. Cancer Res. 2006; 66(23):11314–11322. PubMed PMID:17114238. DOI:10.1158/0008-5472.CAN-06-1199
    • (2006) Cancer Res , vol.66 , Issue.23 , pp. 11314-11322
    • Puttini, M.1    Coluccia, A.M.2    Boschelli, F.3
  • 66
    • 84873618925 scopus 로고    scopus 로고
    • Treating chronic myeloid leukemia: improving management through understanding of the patient experience
    • Simoneau CA. Treating chronic myeloid leukemia:improving management through understanding of the patient experience. Clin J Oncol Nurs. 2013;17(1):E13–20. DOI:10.1188/13.CJON.E13-E20
    • (2013) Clin J Oncol Nurs , vol.17 , Issue.1 , pp. E13-E20
    • Simoneau, C.A.1
  • 67
    • 84957552953 scopus 로고    scopus 로고
    • Tyrosine kinase inhibitor-associated cardiovascular toxicity in chronic myeloid leukemia
    • Moslehi JJ, Deininger M. Tyrosine kinase inhibitor-associated cardiovascular toxicity in chronic myeloid leukemia. J Clin Oncol. 2015;33(35):4210–4218. DOI:10.1200/JCO.2015.62
    • (2015) J Clin Oncol , vol.33 , Issue.35 , pp. 4210-4218
    • Moslehi, J.J.1    Deininger, M.2
  • 68
    • 77953651361 scopus 로고    scopus 로고
    • Pleural effusions due to dasatinib
    • Brixey AG, Light RW. Pleural effusions due to dasatinib. Curr Opin Pulm Med. 2010;16(4):351–356. DOI:10.1097/MCP.0b013e328338c486
    • (2010) Curr Opin Pulm Med , vol.16 , Issue.4 , pp. 351-356
    • Brixey, A.G.1    Light, R.W.2
  • 69
    • 85018728494 scopus 로고    scopus 로고
    • (EMA) EMA. Sprycel® product information. Available from:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000709/WC500056993.pdf
    • Sprycel® product information
  • 70
    • 80055070888 scopus 로고    scopus 로고
    • Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib
    • PubMed PMID: 21865346; PubMed Central PMCID: PMCPMC4916618
    • Cortes JE, Kantarjian HM, Brummendorf TH, et al. Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib. Blood. 2011; 118(17):4567–4576. PubMed PMID:21865346; PubMed Central PMCID:PMCPMC4916618. DOI:10.1182/blood-2011-05-355594
    • (2011) Blood , vol.118 , Issue.17 , pp. 4567-4576
    • Cortes, J.E.1    Kantarjian, H.M.2    Brummendorf, T.H.3
  • 71
    • 84908292829 scopus 로고    scopus 로고
    • Resistant mutations in CML and Ph(+)ALL - role of ponatinib
    • PubMed PMID: 25349473; PubMed Central PMCID: PMCPMC4208348
    • Miller GD, Bruno BJ, Lim CS, Resistant mutations in CML and Ph(+)ALL - role of ponatinib. Biologics. 2014;8:243–254. PubMed PMID:25349473; PubMed Central PMCID:PMCPMC4208348. DOI:10.2147/BTT.S50734
    • (2014) Biologics , vol.8 , pp. 243-254
    • Miller, G.D.1    Bruno, B.J.2    Lim, C.S.3
  • 72
    • 84962310780 scopus 로고    scopus 로고
    • Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
    • Caldemeyer L, Dugan M, Edwards J, Akard L. Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Curr Hematol Malig Rep. 2016 Apr;11(2):71–79.
    • (2016) Curr Hematol Malig Rep , vol.11 , Issue.2 , pp. 71-79
  • 73
    • 84991475849 scopus 로고    scopus 로고
    • Evolving epidemiology of HIV-associated malignancies
    • PubMed PMID: 27749369
    • Shiels MS, Engels EA. Evolving epidemiology of HIV-associated malignancies. Curr Opin HIV AIDS. 2016. PubMed PMID:27749369. DOI:10.1097/COH.0000000000000327
    • (2016) Curr Opin HIV AIDS
    • Shiels, M.S.1    Engels, E.A.2
  • 74
    • 77958553932 scopus 로고    scopus 로고
    • Immunoprofiling of patients with chronic myeloid leukemia at diagnosis and during tyrosine kinase inhibitor therapy
    • Rohon P, Porkka K, Mustjoki S. Immunoprofiling of patients with chronic myeloid leukemia at diagnosis and during tyrosine kinase inhibitor therapy. Eur J Haematol. 2010;85(5):387–398. DOI:10.1111/j.1600-0609.2010.01501.x
    • (2010) Eur J Haematol , vol.85 , Issue.5 , pp. 387-398
    • Rohon, P.1    Porkka, K.2    Mustjoki, S.3
  • 75
    • 4344597828 scopus 로고    scopus 로고
    • Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro
    • PubMed PMID: 15190258
    • Cwynarski K, Laylor R, Macchiarulo E, et al. Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro. Leukemia. 2004; 18(8):1332–1339. PubMed PMID:15190258. DOI:10.1038/sj.leu.2403401
    • (2004) Leukemia , vol.18 , Issue.8 , pp. 1332-1339
    • Cwynarski, K.1    Laylor, R.2    Macchiarulo, E.3
  • 76
    • 53749086585 scopus 로고    scopus 로고
    • Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signalling
    • PubMed PMID: 18194453; PubMed Central PMCID: PMCPMC4506175
    • Chen J, Schmitt A, Chen B, et al. Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signalling. J Cell Mol Med. 2008;12:(5B):2107-18. PubMed PMID:18194453; PubMed Central PMCID:PMCPMC4506175. DOI:10.1111/j.1582-4934.2008.00234.x
    • (2008) J Cell Mol Med , vol.12
    • Chen, J.1    Schmitt, A.2    Chen, B.3
  • 77
    • 38949210227 scopus 로고    scopus 로고
    • Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation
    • PubMed PMID: 17962511; PubMed Central PMCID: PMCPMC2214733
    • Schade AE, Schieven GL, Townsend R, et al. Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation. Blood. 2008; 111(3):1366–1377. PubMed PMID:17962511; PubMed Central PMCID:PMCPMC2214733. DOI:10.1182/blood-2007-04-084814
    • (2008) Blood , vol.111 , Issue.3 , pp. 1366-1377
    • Schade, A.E.1    Schieven, G.L.2    Townsend, R.3
  • 78
    • 77956280601 scopus 로고    scopus 로고
    • Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy
    • PubMed PMID: 20413659
    • Kreutzman A, Juvonen V, Kairisto V, et al. Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy. Blood. 2010;116(5):772–782. PubMed PMID:20413659. DOI:10.1182/blood-2009-12-256800• A description of immunological changes induced by tyrosine kinase inhibitors related with toxic effects.
    • (2010) Blood , vol.116 , Issue.5 , pp. 772-782
    • Kreutzman, A.1    Juvonen, V.2    Kairisto, V.3
  • 79
    • 84876139192 scopus 로고    scopus 로고
    • Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy
    • PubMed PMID: 23192016
    • Mustjoki S, Auvinen K, Kreutzman A, et al. Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy. Leukemia. 2013; 27(4):914–924. PubMed PMID:23192016. DOI:10.1038/leu.2012.348
    • (2013) Leukemia , vol.27 , Issue.4 , pp. 914-924
    • Mustjoki, S.1    Auvinen, K.2    Kreutzman, A.3
  • 80
    • 84961726913 scopus 로고    scopus 로고
    • Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: effects on response and toxicity
    • PubMed PMID: 26998677
    • Schiffer CA, Cortes JE, Hochhaus A, et al. Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia:effects on response and toxicity. Cancer. 2016;122(9):1398–1407. PubMed PMID:26998677. DOI:10.1002/cncr.29933• A description of the potential role of recovered lymphocytes in the response and control of chronic myeloid leukemia.
    • (2016) Cancer , vol.122 , Issue.9 , pp. 1398-1407
    • Schiffer, C.A.1    Cortes, J.E.2    Hochhaus, A.3
  • 81
    • 84864252696 scopus 로고    scopus 로고
    • Characteristics of, and risk factors for, infections in patients with cancer treated with dasatinib and a brief review of other complications
    • Rodriguez GH, Ahmed SI, Al-Akhrass F, et al. Characteristics of, and risk factors for, infections in patients with cancer treated with dasatinib and a brief review of other complications. Leuk Lymphoma. 2012;53(8):1530–1535. DOI:10.3109/10428194.2012.656626
    • (2012) Leuk Lymphoma , vol.53 , Issue.8 , pp. 1530-1535
    • Rodriguez, G.H.1    Ahmed, S.I.2    Al-Akhrass, F.3
  • 82
    • 84988515291 scopus 로고    scopus 로고
    • Dual targeting of the thioredoxin and glutathione systems in cancer and HIV
    • Benhar M, Shytaj IL, Stamler JS, et al. Dual targeting of the thioredoxin and glutathione systems in cancer and HIV. J Clin Invest. 2016;126(5):1630–1639. DOI:10.1172/JCI85339
    • (2016) J Clin Invest , vol.126 , Issue.5 , pp. 1630-1639
    • Benhar, M.1    Shytaj, I.L.2    Stamler, J.S.3
  • 83
    • 45749134564 scopus 로고    scopus 로고
    • The anticancer immune response: indispensable for therapeutic success?
    • Zitvogel L, Apetoh L, Ghiringhelli F, et al. The anticancer immune response:indispensable for therapeutic success? J Clin Invest. 2008;118(6):1991–2001. DOI:10.1172/JCI35180
    • (2008) J Clin Invest , vol.118 , Issue.6 , pp. 1991-2001
    • Zitvogel, L.1    Apetoh, L.2    Ghiringhelli, F.3
  • 84
    • 79960974038 scopus 로고    scopus 로고
    • Protein kinase Ctheta is a specific target for inhibition of the HIV type 1 replication in CD4+ T lymphocytes
    • PubMed PMID: 21669868; PubMed Central PMCID: PMCPMC3149330
    • Lopez-Huertas MR, Mateos E, Diaz-Gil G, et al. Protein kinase Ctheta is a specific target for inhibition of the HIV type 1 replication in CD4+ T lymphocytes. J Biol Chem. 2011; 286(31):27363–27377. PubMed PMID:21669868; PubMed Central PMCID:PMCPMC3149330. DOI:10.1074/jbc.M110.210443
    • (2011) J Biol Chem , vol.286 , Issue.31 , pp. 27363-27377
    • Lopez-Huertas, M.R.1    Mateos, E.2    Diaz-Gil, G.3
  • 85
    • 84862777555 scopus 로고    scopus 로고
    • SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates
    • 2236. PubMed PMID: 22327569; PubMed Central PMCID: PMCPMC3771401
    • Lahouassa H, Daddacha W, Hofmann H, et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol. 2012; 13(3):223–228. 2236. PubMed PMID:22327569; PubMed Central PMCID:PMCPMC3771401. DOI:10.1038/ni
    • (2012) Nat Immunol , vol.13 , Issue.3 , pp. 223-228
    • Lahouassa, H.1    Daddacha, W.2    Hofmann, H.3
  • 86
    • 84876972365 scopus 로고    scopus 로고
    • Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1
    • Cribier A, Descours B, Valadao AL, et al. Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. Cell Rep. 2013;3(4):1036–1043. DOI:10.1016/j.celrep.2013.03.017
    • (2013) Cell Rep , vol.3 , Issue.4 , pp. 1036-1043
    • Cribier, A.1    Descours, B.2    Valadao, A.L.3
  • 87
    • 84904541265 scopus 로고    scopus 로고
    • Evaluating the promiscuous nature of tyrosine kinase inhibitors assessed in A431 epidermoid carcinoma cells by both chemical- and phosphoproteomics
    • PubMed PMID: 24804581
    • Giansanti P, Preisinger C, Huber KV, et al. Evaluating the promiscuous nature of tyrosine kinase inhibitors assessed in A431 epidermoid carcinoma cells by both chemical- and phosphoproteomics. ACS Chem Biol. 2014; 9(7):1490–1498. PubMed PMID:24804581. DOI:10.1021/cb500116c
    • (2014) ACS Chem Biol , vol.9 , Issue.7 , pp. 1490-1498
    • Giansanti, P.1    Preisinger, C.2    Huber, K.V.3
  • 88
    • 84898423894 scopus 로고    scopus 로고
    • New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
    • Bullen CK, Laird GM, Durand CM, et al. New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo. Nat Med. 2014;20(4):425–429. DOI:10.1038/nm
    • (2014) Nat Med , vol.20 , Issue.4 , pp. 425-429
    • Bullen, C.K.1    Laird, G.M.2    Durand, C.M.3
  • 89
    • 79551614790 scopus 로고    scopus 로고
    • HIV infection, inflammation, immunosenescence, and aging
    • PubMed PMID: 21090961; PubMed Central PMCID: PMCPMC3759035
    • Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med PubMed PMID:21090961; PubMed Central PMCID:PMCPMC3759035. 2011;62:141–155. DOI:10.1146/annurev-med-042909-093756•• A review on the pathogenic mechanisms leading to immunological damage due to chronic activation and exhaustion of the immune system by persistent HIV replication.
    • (2011) Annu Rev Med , vol.62 , pp. 141-155
    • Deeks, S.G.1
  • 90
    • 84872675899 scopus 로고    scopus 로고
    • Aging, inflammation, and HIV infection
    • PubMed PMID: 22954610
    • Aberg JA, Aging, inflammation, and HIV infection. Top Antivir Med. 2012;203:101–105.PubMed PMID:22954610.
    • (2012) Top Antivir Med , vol.20 , Issue.3 , pp. 101-105
    • Aberg, J.A.1
  • 91
    • 84973176467 scopus 로고    scopus 로고
    • The concept of treatment-free remission in chronic myeloid leukemia
    • PubMed PMID: 27133824; PubMed Central PMCID: PMCPMC4980559
    • Saussele S, Richter J, Hochhaus A, et al. The concept of treatment-free remission in chronic myeloid leukemia. Leukemia. 2016;30(8):1638–1647. PubMed PMID:27133824; PubMed Central PMCID:PMCPMC4980559. DOI:10.1038/leu.2016.115• A concept paper discussing the successful interruption of treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukemia that show deep molecular response.
    • (2016) Leukemia , vol.30 , Issue.8 , pp. 1638-1647
    • Saussele, S.1    Richter, J.2    Hochhaus, A.3
  • 92
    • 84960941451 scopus 로고    scopus 로고
    • Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial
    • PubMed PMID: 26686407
    • Imagawa J, Tanaka H, Okada M, et al. Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial):a multicentre phase 2 trial. Lancet Haematol. 2015; 2(12):e528–35. PubMed PMID:26686407. DOI:10.1016/S2352-3026(15)00196-9
    • (2015) Lancet Haematol , vol.2 , Issue.12 , pp. e528-e535
    • Imagawa, J.1    Tanaka, H.2    Okada, M.3
  • 93
    • 84883446131 scopus 로고    scopus 로고
    • Sustained upregulation of effector natural killer cells in chronic myeloid leukemia after discontinuation of imatinib
    • PubMed PMID: 23758044
    • Mizoguchi I, Yoshimoto T, Katagiri S, et al. Sustained upregulation of effector natural killer cells in chronic myeloid leukemia after discontinuation of imatinib. Cancer Sci. 2013; 104(9):1146–1153. PubMed PMID:23758044. DOI:10.1111/cas.12216
    • (2013) Cancer Sci , vol.104 , Issue.9 , pp. 1146-1153
    • Mizoguchi, I.1    Yoshimoto, T.2    Katagiri, S.3
  • 94
    • 84962090744 scopus 로고    scopus 로고
    • Immunological off-target effects of imatinib
    • Zitvogel L, Rusakiewicz S, Routy B, et al. Immunological off-target effects of imatinib. Nat Rev Clin Oncol. 2016;13(7):431–446. DOI:10.1038/nrclinonc.2016.41
    • (2016) Nat Rev Clin Oncol , vol.13 , Issue.7 , pp. 431-446
    • Zitvogel, L.1    Rusakiewicz, S.2    Routy, B.3
  • 95
    • 84944584173 scopus 로고    scopus 로고
    • Imatinib for highly chemoresistant Kaposi sarcoma in a patient with long-term HIV control: a case report and literature review
    • Cao W, Vyboh K, Routy B, et al. Imatinib for highly chemoresistant Kaposi sarcoma in a patient with long-term HIV control:a case report and literature review. Curr Oncol. 2015;22(5):e395–9. DOI:10.3747/co.22
    • (2015) Curr Oncol , vol.22 , Issue.5 , pp. e395-e399
    • Cao, W.1    Vyboh, K.2    Routy, B.3
  • 96
    • 84859250847 scopus 로고    scopus 로고
    • Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection
    • PubMed PMID: 22479485; PubMed Central PMCID: PMCPMC3316511
    • Ananworanich J, Schuetz A, Vandergeeten C, et al. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. Plos One. 2012; 7(3):e33948. PubMed PMID:22479485; PubMed Central PMCID:PMCPMC3316511. DOI:10.1371/journal.pone.0033948
    • (2012) Plos One , vol.7 , Issue.3 , pp. e33948
    • Ananworanich, J.1    Schuetz, A.2    Vandergeeten, C.3
  • 97
    • 84911005050 scopus 로고    scopus 로고
    • Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells
    • PubMed PMID: 24965451; PubMed Central PMCID: PMCPMC4136362
    • Buzon MJ, Martin-Gayo E, Pereyra F, et al. Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells. J Virol. 2014;88(17):10056–10065. PubMed PMID:24965451; PubMed Central PMCID:PMCPMC4136362. DOI:10.1128/JVI.01046-14• This article describes the impact of early treatment on the establishment and size of the HIV reservoir.
    • (2014) J Virol , vol.88 , Issue.17 , pp. 10056-10065
    • Buzon, M.J.1    Martin-Gayo, E.2    Pereyra, F.3
  • 98
    • 0041828179 scopus 로고    scopus 로고
    • Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection
    • PubMed PMID: 12960819
    • Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors:implications for diagnosis and staging of primary HIV infection. Aids. 2003;17(13):1871–1879. PubMed PMID:12960819. DOI:10.1097/01.aids.0000076308.76477.b8•• Classical article describing the criteria to define the different stages in acute HIV-1 infection.
    • (2003) Aids , vol.17 , Issue.13 , pp. 1871-1879
    • Fiebig, E.W.1    Wright, D.J.2    Rawal, B.D.3
  • 99
    • 84941745031 scopus 로고    scopus 로고
    • Magnitude and kinetics of CD8+ T cell activation during hyperacute HIV infection impact viral set point
    • PubMed PMID: 26362266; PubMed Central PMCID: PMCPMC4575777
    • Ndhlovu ZM, Kamya P, Mewalal N, et al. Magnitude and kinetics of CD8+ T cell activation during hyperacute HIV infection impact viral set point. Immunity. 2015; 43(3):591–604. PubMed PMID:26362266; PubMed Central PMCID:PMCPMC4575777. DOI:10.1016/j.immuni.2015.08.012
    • (2015) Immunity , vol.43 , Issue.3 , pp. 591-604
    • Ndhlovu, Z.M.1    Kamya, P.2    Mewalal, N.3
  • 100
    • 84958108976 scopus 로고    scopus 로고
    • Innate lymphoid cells are depleted irreversibly during acute HIV-1 infection in the absence of viral suppression
    • PubMed PMID: 26850658
    • Kloverpris HN, Kazer SW, Mjosberg J, et al. Innate lymphoid cells are depleted irreversibly during acute HIV-1 infection in the absence of viral suppression. Immunity. 2016; 44(2):391–405. PubMed PMID:26850658. DOI:10.1016/j.immuni.2016.01.006
    • (2016) Immunity , vol.44 , Issue.2 , pp. 391-405
    • Kloverpris, H.N.1    Kazer, S.W.2    Mjosberg, J.3
  • 101
    • 84922764937 scopus 로고    scopus 로고
    • Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
    • PubMed PMID: 25561180; PubMed Central PMCID: PMCPMC4406054
    • Deng K, Pertea M, Rongvaux A, et al. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations. Nature. 2015; 517(7534):381–385. PubMed PMID:25561180; PubMed Central PMCID:PMCPMC4406054. DOI:10.1038/nature14053
    • (2015) Nature , vol.517 , Issue.7534 , pp. 381-385
    • Deng, K.1    Pertea, M.2    Rongvaux, A.3
  • 102
    • 84937682389 scopus 로고    scopus 로고
    • Two-year follow-up of macaques developing intermittent control of the human immunodeficiency virus homolog simian immunodeficiency virus SIVmac251 in the chronic phase of infection
    • PubMed PMID: 25972547; PubMed Central PMCID: PMCPMC4505651
    • Shytaj IL, Nickel G, Arts E, et al. Two-year follow-up of macaques developing intermittent control of the human immunodeficiency virus homolog simian immunodeficiency virus SIVmac251 in the chronic phase of infection. J Virol. 2015; 89(15):7521–7535. PubMed PMID:25972547; PubMed Central PMCID:PMCPMC4505651. DOI:10.1128/JVI.00396-15
    • (2015) J Virol , vol.89 , Issue.15 , pp. 7521-7535
    • Shytaj, I.L.1    Nickel, G.2    Arts, E.3
  • 103
    • 77954666282 scopus 로고    scopus 로고
    • Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step
    • Harmon B, Campbell N, Ratner L. Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step. Plos Pathog. 2010;6(6):e1000956. DOI:10.1371/journal.ppat.1000956
    • (2010) Plos Pathog , vol.6 , Issue.6 , pp. e1000956
    • Harmon, B.1    Campbell, N.2    Ratner, L.3
  • 104
    • 84892369558 scopus 로고    scopus 로고
    • The tyrosine kinase inhibitor Dasatinib blocks in-vitro HIV-1 production by primary CD4+ T cells from HIV-1 infected patients
    • PubMed PMID: 24361684
    • Pogliaghi M, Papagno L, Lambert S, et al. The tyrosine kinase inhibitor Dasatinib blocks in-vitro HIV-1 production by primary CD4+ T cells from HIV-1 infected patients. Aids. 2014; 28(2):278–281. PubMed PMID:24361684. DOI:10.1097/QAD.0000000000000073
    • (2014) Aids , vol.28 , Issue.2 , pp. 278-281
    • Pogliaghi, M.1    Papagno, L.2    Lambert, S.3
  • 105
    • 84890478626 scopus 로고    scopus 로고
    • Bone marrow abnormalities in HIV disease
    • Dhurve SA, Dhurve AS. Bone marrow abnormalities in HIV disease. Mediterr J Hematol Infect Dis. 2013;5(1):e2013033. DOI:10.4084/MJHID.2013.033
    • (2013) Mediterr J Hematol Infect Dis , vol.5 , Issue.1 , pp. e2013033
    • Dhurve, S.A.1    Dhurve, A.S.2
  • 106
    • 84902480343 scopus 로고    scopus 로고
    • Update on antiretroviral treatment during primary HIV infection
    • Ambrosioni J, Nicolas D, Sued O, et al. Update on antiretroviral treatment during primary HIV infection. Expert Rev Anti Infect Ther. 2014;12(7):793–807. DOI:10.1586/14787210.2014.913981
    • (2014) Expert Rev Anti Infect Ther , vol.12 , Issue.7 , pp. 793-807
    • Ambrosioni, J.1    Nicolas, D.2    Sued, O.3
  • 107
    • 84941414260 scopus 로고    scopus 로고
    • Reactivation of resolved infection with the hepatitis B virus immune escape mutant G145R during dasatinib treatment for chronic myeloid leukemia
    • PubMed PMID: 25842192
    • Ando T, Kojima K, Isoda H, et al. Reactivation of resolved infection with the hepatitis B virus immune escape mutant G145R during dasatinib treatment for chronic myeloid leukemia. Int J Hematol. 2015; 102(3):379–382. PubMed PMID:25842192. DOI:10.1007/s12185-015-1788-y
    • (2015) Int J Hematol , vol.102 , Issue.3 , pp. 379-382
    • Ando, T.1    Kojima, K.2    Isoda, H.3
  • 108
    • 84939000210 scopus 로고    scopus 로고
    • Emerging challenges in managing hepatitis B in HIV patients
    • PubMed PMID: 26156570
    • Soriano V, Labarga P, De Mendoza C, et al. Emerging challenges in managing hepatitis B in HIV patients. Curr HIV/AIDS Rep. 2015; 12(3):344–352. PubMed PMID:26156570. DOI:10.1007/s11904-015-0275-7
    • (2015) Curr HIV/AIDS Rep , vol.12 , Issue.3 , pp. 344-352
    • Soriano, V.1    Labarga, P.2    De Mendoza, C.3
  • 109
    • 84969988129 scopus 로고    scopus 로고
    • Drug interactions with cobicistat- or ritonavir-boosted elvitegravir
    • PubMed PMID: 27196356
    • Nguyen T, McNicholl I, Custodio JM, et al., Drug interactions with cobicistat- or ritonavir-boosted elvitegravir. AIDS Rev. 2016;182:101–111.PubMed PMID:27196356.
    • (2016) AIDS Rev , vol.18 , Issue.2 , pp. 101-111
    • Nguyen, T.1    McNicholl, I.2    Custodio, J.M.3
  • 110
    • 77949369418 scopus 로고    scopus 로고
    • Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors
    • PubMed PMID: 20108303
    • Johnson FM, Agrawal S, Burris H, et al. Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors. Cancer. 2010; 116(6):1582–1591. PubMed PMID:20108303. DOI:10.1002/cncr.24927
    • (2010) Cancer , vol.116 , Issue.6 , pp. 1582-1591
    • Johnson, F.M.1    Agrawal, S.2    Burris, H.3
  • 111
    • 84964461243 scopus 로고    scopus 로고
    • Clinical pharmacokinetics and pharmacodynamics of bosutinib
    • Abbas R, Hsyu PH. Clinical pharmacokinetics and pharmacodynamics of bosutinib. Clin Pharmacokinet. 2016;55(10):1191–1204. DOI:10.1007/s40262-016-0391-6
    • (2016) Clin Pharmacokinet , vol.55 , Issue.10 , pp. 1191-1204
    • Abbas, R.1    Hsyu, P.H.2
  • 112
    • 85018772050 scopus 로고    scopus 로고
    • Available from
    • (EMA) EMA. Iclusig® Prescribing Information. Available from http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/002695/WC500145649.pdf
    • Iclusig® Prescribing Information
  • 113
    • 85018737904 scopus 로고    scopus 로고
    • EACS 2017. Available from:http://www.eacsociety.org/files/guidelines_8.2-english.pdf
    • (2017)
  • 114
    • 84978371920 scopus 로고    scopus 로고
    • Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the international antiviral society-USA panel
    • 8900. PubMed PMID: 27404187; PubMed Central PMCID: PMCPMC5012643
    • Gunthard HF, Saag MS, Benson CA, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults:2016 recommendations of the international antiviral society-USA panel. Jama. 2016; 316(2):191–210. 8900. PubMed PMID:27404187; PubMed Central PMCID:PMCPMC5012643. DOI:10.1001/jama.2016
    • (2016) Jama , vol.316 , Issue.2 , pp. 191-210
    • Gunthard, H.F.1    Saag, M.S.2    Benson, C.A.3
  • 115
    • 62249172189 scopus 로고    scopus 로고
    • Enhancing SIV-specific immunity in vivo by PD-1 blockade
    • PubMed PMID: 19078956; PubMed Central PMCID: PMCPMC2753387
    • Velu V, Titanji K, Zhu B, et al. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature. 2009; 458(7235):206–210. PubMed PMID:19078956; PubMed Central PMCID:PMCPMC2753387. DOI:10.1038/nature07662
    • (2009) Nature , vol.458 , Issue.7235 , pp. 206-210
    • Velu, V.1    Titanji, K.2    Zhu, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.